BCR and chronic myelogenous leukemia, BCR-ABL1 positive: This case emphasizes the requirement for molecular monitoring in CML patients with atypical <i>BCR-ABL1</i> fusion transcripts and emphasizes that comprehensive sequencing has the potential to identify targets for novel therapies in CML patients with advanced disease.